In January 2010, Andrew Witty realized that pharmaceutical patent pool itself was not enough to generate action on neglected tropical diseases. He declared, so "Open Labs, Open Minds" strategy. Was this enough to encourage action for neglected diseases affecting the poorest in the world? How to GSK shareholders react? "Hide
by Michael Rose, Chander Sehgal Source: Richard Ivey School of Business Foundation 4 pages. Publication Date: March 8, 2011. Prod. #: W10016-PDF-ENG
Related Case Solutions & Analyses:
Chicken and Egg: Study of the Poultry Genetics Industry
Guest-Tek Interactive Entertainment: International Sales
Turning Around Organizations in a Crisis: The Case of Two Major Alberta Orchestras
lululemon athletica: Selling Over the Internet
Citigroup in Post-WTO China (B)
Canning Consultants: The OPAC Assessment
Laboratorio de Analisis Argentina
Kraves Candy Co.–Clodhoppers (A)
American Cyanamid
Kobe Steel USElectronic Materials Center: The Commercialization of New Technology (B)
